156 related articles for article (PubMed ID: 7509305)
1. [Finasteride (Proscar) for benign prostatic hypertrophy].
Matzkin H; Chen J; Braf Z
Harefuah; 1993 Dec; 125(12):453-6, 496. PubMed ID: 7509305
[TBL] [Abstract][Full Text] [Related]
2. [The treatment of patients with benign prostatic hyperplasia with Proscar MSD (finasteride)].
Stepanov VN; Teodorovich OV; Seregin AV; Kadyrov ZA
Urol Nefrol (Mosk); 1995; (5):28-30. PubMed ID: 8571480
[TBL] [Abstract][Full Text] [Related]
3. 5alpha-reductase inhibitors/finasteride.
Stoner E
Prostate Suppl; 1996; 6():82-7. PubMed ID: 8630236
[TBL] [Abstract][Full Text] [Related]
4. [The long-term treatment of patients with benign prostatic hyperplasia using Proscar].
Lopatkin NA; Roilans PJ; Stoner E
Urol Nefrol (Mosk); 1996; (1):2-4. PubMed ID: 8659035
[TBL] [Abstract][Full Text] [Related]
5. [Long-term results of proscar (finasteride, MSD) treatment of patients with benign prostatic hyperplasia].
Tkachuk VN; Al'-Shukri SKh; Kornienko VI; Kuz'min IV
Urol Nefrol (Mosk); 1998; (4):37-9. PubMed ID: 9727320
[TBL] [Abstract][Full Text] [Related]
6. Finasteride in the treatment of benign prostatic hyperplasia.
Ekman P; Andersen JT; Wolf H
Acta Urol Belg; 1996 Mar; 64(1):IX-XII. PubMed ID: 8659328
[TBL] [Abstract][Full Text] [Related]
7. Effect of long-term administration of finasteride (MK-906), an inhibitor of 5 alpha-reductase, in patients with benign prostatic hyperplasia.
Yoshida O; Oishi K; Okada Y; Mizutani Y; Itokawa Y; Tomoyoshi T; Okada K; Komatz Y; Matsuda T; Takeuchi H
Hinyokika Kiyo; 1996 Apr; 42(4):323-31. PubMed ID: 8693970
[TBL] [Abstract][Full Text] [Related]
8. [A trial of the use of finasteride and terazosin in patients with benign prostatic hyperplasia].
Pushkar' DIu; Kosko DV; Loran OB; Kan IaD; Sapozhnikov IM; Tevlin KP
Urol Nefrol (Mosk); 1995; (4):32-5. PubMed ID: 7571199
[TBL] [Abstract][Full Text] [Related]
9. One-year experience in the treatment of benign prostatic hyperplasia with finasteride. The MK-906 (Finasteride) Study Group.
J Androl; 1991; 12(6):372-5. PubMed ID: 1722792
[TBL] [Abstract][Full Text] [Related]
10. Current treatment of BPH.
Roylance P; Gibelin B; Espié J
Biomed Pharmacother; 1995; 49(7-8):332-8. PubMed ID: 8562858
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic effect of harnal and proscar in treating benign prostatic hyperplasia].
Tang ZY; Peng KL; Ding J; Zu XB; Qi L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):708-10. PubMed ID: 16708816
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of men on finasteride.
Gormley GJ
Semin Urol Oncol; 1996 Aug; 14(3):139-44. PubMed ID: 8865475
[TBL] [Abstract][Full Text] [Related]
13. Finasteride for benign prostatic hyperplasia.
Hasinski S; Miller JL; Rose LI
Am Fam Physician; 1992 Nov; 46(5):1511-4. PubMed ID: 1279965
[TBL] [Abstract][Full Text] [Related]
14. [New prospective therapy for benign prostatic hyperplasia with finasteride].
Miano L; Manieri C; Paradiso Galatioto G; Vicentini C
Riv Eur Sci Med Farmacol; 1993; 15(2):111-9. PubMed ID: 7513437
[TBL] [Abstract][Full Text] [Related]
15. Prevalent decrease of the EGF content in the periurethral zone of BPH tissue induced by treatment with finasteride or flutamide.
Monti S; Sciarra F; Adamo MV; Toscano V; Trotta MC; Martini C; Lanzara S; Silverio FD
J Androl; 1997; 18(5):488-94. PubMed ID: 9349746
[TBL] [Abstract][Full Text] [Related]
16. [Medical treatment of benign prostatic hyperplasia. The efficacy of finasteride depends on prostatic volume].
Granados Loarca EA
Arch Esp Urol; 1999 Apr; 52(3):201-8. PubMed ID: 10371735
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of benign prostatic hyperplasia with Proscar (finasteride). Results of a 10-year Scandinavian study].
Tveter KJ; Beisland HO; Andersen JT; Wolf H; Ekman P; Johansson JE; Kontturi M; Lehtonen T
Tidsskr Nor Laegeforen; 1996 Nov; 116(27):3226-30. PubMed ID: 9011975
[TBL] [Abstract][Full Text] [Related]
18. [Benign prostatic hyperplasia--its treatment with Proscar].
Panchev P; Neĭkov K; Simeonov P
Khirurgiia (Sofiia); 1996; 49(1):15-8. PubMed ID: 8975081
[TBL] [Abstract][Full Text] [Related]
19. An economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasia.
McDonald H; Hux M; Brisson M; Bernard L; Nickel JC
Can J Urol; 2004 Aug; 11(4):2327-40. PubMed ID: 15380054
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
Habib FK; Ross M; Tate R; Chisholm GD
Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
